Pyrimidine derivatives of formula (I) and
1
the physiologically acceptable salts thereof,
where R1, R2, R3, R4, W, X, Y and Z have the meanings given in claim
1,
display a phosphodiesterase V inhibition and can be used for treatment of diseases of the coronary circulatory system and for treatment and/or therapy of potency disorders.